Sub menu

 
 

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset.

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

Topics

AusPAR Date

1062 result(s) found, displaying 326 to 350

  • AusPAR: Baloxavir marboxil

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Baloxavir marboxil

  • AusPAR: Fondaparinux

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Fondaparinux

  • AusPAR: Neratinib (as maleate)

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Neratinib (as maleate)

  • AusPAR: Pembrolizumab (rch)

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Pembrolizumab (rch)

  • AusPAR: Caplacizumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Caplacizumab

  • AusPAR: Ciclosporin

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Ciclosporin

  • AusPAR: Enasidenib

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Enasidenib

  • AusPAR: Upadacitinib

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Upadacitinib

  • AusPAR: Brolucizumab (rbe)

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Brolucizumab (rbe)

  • AusPAR: Nivolumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Nivolumab

  • AusPAR: Brigatinib

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Brigatinib

  • AusPAR: Trastuzumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Trastuzumab

  • AusPAR: Lanadelumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Takhzyro

  • AusPAR: Mecasermin

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Mecasermin

  • AusPAR: Ceritinib

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Ceritinib

  • AusPAR: Bevacizumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Bevacizumab

  • AusPAR: Ceftazidime/Avibactam

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Ceftazidime/Avibactam

  • AusPAR: Acalabrutinib

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Acalabrutinib

  • AusPAR: Lorlatinib

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Lorlatinib

  • AusPAR: Mepolizumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Mepolizumab

  • AusPAR: Acalabrutinib

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Acalabrutinib

Help us improve the Therapeutic Goods Administration site